{"entity":{"type":"insider","cik":"0001788580","url":"/insider/0001788580","json_url":"/insider/0001788580.json","name":"Crockett Nigel","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":11,"first":"2021-07-08","last":"2025-01-06","span_basis":"filed_date"},"name_variants":[{"name":"Crockett Nigel","source":"filing","n_filings":11,"first_seen":"2021-07-08","last_seen":"2025-01-06"}],"transactions":[{"id":4706057,"accession":"0001415889-25-000925","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-000925","line_url":"/filing/0001415889-25-000925#line-3","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001788580","owner_name":"Crockett Nigel","owner_display_name":"Crockett Nigel","owner_url":"/insider/0001788580","role":"Officer (CHIEF BUSINESS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF BUSINESS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF BUSINESS OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":936.0,"shares_display":"936","price_per_share":14.75,"price_display":"14.75","price_state":"stated","total_value":13806.0,"total_display":"13,806.00","total_whole":"13,806","shares_owned_after":51053.0,"shares_owned_after_display":"51,053","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-03","filed_date":"2025-01-06","scope":"insider"},{"id":4706050,"accession":"0001415889-25-000925","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-000925","line_url":"/filing/0001415889-25-000925#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001788580","owner_name":"Crockett Nigel","owner_display_name":"Crockett Nigel","owner_url":"/insider/0001788580","role":"Officer (CHIEF BUSINESS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF BUSINESS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF BUSINESS OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2583.0,"shares_display":"2,583","price_per_share":14.09,"price_display":"14.09","price_state":"stated","total_value":36394.47,"total_display":"36,394.47","total_whole":"36,394","shares_owned_after":51989.0,"shares_owned_after_display":"51,989","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-02","filed_date":"2025-01-06","scope":"insider"},{"id":2190838,"accession":"0001415889-24-024768","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-024768","line_url":"/filing/0001415889-24-024768#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001788580","owner_name":"Crockett Nigel","owner_display_name":"Crockett Nigel","owner_url":"/insider/0001788580","role":"Officer (CHIEF BUSINESS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF BUSINESS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF BUSINESS OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":972.0,"shares_display":"972","price_per_share":22.26,"price_display":"22.26","price_state":"stated","total_value":21636.72,"total_display":"21,636.72","total_whole":"21,637","shares_owned_after":45822.0,"shares_owned_after_display":"45,822","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-03","filed_date":"2024-10-04","scope":"insider"},{"id":2070114,"accession":"0001415889-24-019386","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-019386","line_url":"/filing/0001415889-24-019386#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001788580","owner_name":"Crockett Nigel","owner_display_name":"Crockett Nigel","owner_url":"/insider/0001788580","role":"Officer (CHIEF BUSINESS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF BUSINESS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF BUSINESS OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":967.0,"shares_display":"967","price_per_share":19.64,"price_display":"19.64","price_state":"stated","total_value":18991.88,"total_display":"18,991.88","total_whole":"18,992","shares_owned_after":46794.0,"shares_owned_after_display":"46,794","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-03","filed_date":"2024-07-08","scope":"insider"},{"id":3053295,"accession":"0001415889-24-010415","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-010415","line_url":"/filing/0001415889-24-010415#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001788580","owner_name":"Crockett Nigel","owner_display_name":"Crockett Nigel","owner_url":"/insider/0001788580","role":"Officer (CHIEF BUSINESS OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF BUSINESS OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF BUSINESS OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":955.0,"shares_display":"955","price_per_share":23.81,"price_display":"23.81","price_state":"stated","total_value":22738.55,"total_display":"22,738.55","total_whole":"22,739","shares_owned_after":47761.0,"shares_owned_after_display":"47,761","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-03","filed_date":"2024-04-05","scope":"insider"},{"id":2037756,"accession":"0001209191-24-000879","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-000879","line_url":"/filing/0001209191-24-000879#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001788580","owner_name":"Crockett Nigel","owner_display_name":"Crockett Nigel","owner_url":"/insider/0001788580","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2643.0,"shares_display":"2,643","price_per_share":17.5,"price_display":"17.50","price_state":"stated","total_value":46252.5,"total_display":"46,252.50","total_whole":"46,253","shares_owned_after":48716.0,"shares_owned_after_display":"48,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-03","filed_date":"2024-01-04","scope":"insider"},{"id":8405449,"accession":"0001209191-23-052252","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-052252","line_url":"/filing/0001209191-23-052252#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001788580","owner_name":"Crockett Nigel","owner_display_name":"Crockett Nigel","owner_url":"/insider/0001788580","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":442.0,"shares_display":"442","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":8840.0,"total_display":"8,840.00","total_whole":"8,840","shares_owned_after":29359.0,"shares_owned_after_display":"29,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-03","filed_date":"2023-10-05","scope":"insider"},{"id":7835900,"accession":"0001209191-23-041569","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-041569","line_url":"/filing/0001209191-23-041569#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001788580","owner_name":"Crockett Nigel","owner_display_name":"Crockett Nigel","owner_url":"/insider/0001788580","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":451.0,"shares_display":"451","price_per_share":25.1,"price_display":"25.10","price_state":"stated","total_value":11320.1,"total_display":"11,320.10","total_whole":"11,320","shares_owned_after":29801.0,"shares_owned_after_display":"29,801","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-03","filed_date":"2023-07-06","scope":"insider"},{"id":8332184,"accession":"0001209191-23-023344","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-023344","line_url":"/filing/0001209191-23-023344#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001788580","owner_name":"Crockett Nigel","owner_display_name":"Crockett Nigel","owner_url":"/insider/0001788580","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":447.0,"shares_display":"447","price_per_share":21.11,"price_display":"21.11","price_state":"stated","total_value":9436.17,"total_display":"9,436.17","total_whole":"9,436","shares_owned_after":30252.0,"shares_owned_after_display":"30,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-03","filed_date":"2023-04-05","scope":"insider"},{"id":8034494,"accession":"0001209191-23-002211","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-002211","line_url":"/filing/0001209191-23-002211#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001788580","owner_name":"Crockett Nigel","owner_display_name":"Crockett Nigel","owner_url":"/insider/0001788580","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1801.0,"shares_display":"1,801","price_per_share":29.06,"price_display":"29.06","price_state":"stated","total_value":52337.06,"total_display":"52,337.06","total_whole":"52,337","shares_owned_after":30699.0,"shares_owned_after_display":"30,699","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-05","scope":"insider"},{"id":4622966,"accession":"0001209191-21-046700","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-21-046700","line_url":"/filing/0001209191-21-046700","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001788580","owner_name":"Crockett Nigel","owner_display_name":"Crockett Nigel","owner_url":"/insider/0001788580","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":72701.0,"shares_display":"72,701","price_per_share":32.43919189557228,"price_display":"32.44","price_state":"stated","total_value":2358361.69,"total_display":"2,358,361.69","total_whole":"2,358,362","shares_owned_after":3121.0,"shares_owned_after_display":"3,121","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-13","filed_date":"2021-07-14","scope":"insider","n_lines":2},{"id":4622945,"accession":"0001209191-21-046700","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-046700","line_url":"/filing/0001209191-21-046700#line-4","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001788580","owner_name":"Crockett Nigel","owner_display_name":"Crockett Nigel","owner_url":"/insider/0001788580","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7028.0,"shares_display":"7,028","price_per_share":32.03,"price_display":"32.03","price_state":"stated","total_value":225106.84,"total_display":"225,106.84","total_whole":"225,107","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-12","filed_date":"2021-07-14","scope":"insider"},{"id":5046625,"accession":"0001209191-21-046009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-046009","line_url":"/filing/0001209191-21-046009#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001788580","owner_name":"Crockett Nigel","owner_display_name":"Crockett Nigel","owner_url":"/insider/0001788580","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":271.0,"shares_display":"271","price_per_share":32.0,"price_display":"32.00","price_state":"stated","total_value":8672.0,"total_display":"8,672.00","total_whole":"8,672","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-06","filed_date":"2021-07-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001761612","name":"BICYCLE THERAPEUTICS PLC","url":"/issuer/0001761612","role":"Officer (CHIEF BUSINESS OFFICER)","n_filings":11,"first_seen":"2021-07-08","last_seen":"2025-01-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001788580","retrieved_at":"2026-08-25T03:36:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}